[Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab].
Maalouf
E
E
Service de Dermatologie, Hôpital Henri Mondor, Créteil.
Faye
O
O
Poli
F
F
Cosnes
A
A
Revuz
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002081:Buttocks; D002294:Carcinoma, Squamous Cell / Q000150:complications*; D003879:Dermatologic Agents / Q000627:therapeutic use; D017809:Fatal Outcome; D017497:Hidradenitis Suppurativa / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000150:complications*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab